A non-invasive method for estimating the severity of liver steatosis and the risk of fibrosis in non-obese type 2 diabetes patients with NAFLD.

导出 LinkOut

翻译打印收藏纠错

第一作者： B,Mitrovic

第一单位： Zemun Clinical Hospital, Faculty of Medicine, University of Belgrade - Department of Endocrinology and Diabetes, Belgrade, Serbia.

作者： B,Mitrovic ^[1] ; Z,Gluvic ^[1] ; A,Klisic ^[2] ; M,Obradovic ^[3] ; D,Macut ^[4] ; R,Tomasevic ^[5] ; E R,Isenovic ^[3]

作者单位： Zemun Clinical Hospital, Faculty of Medicine, University of Belgrade - Department of Endocrinology and Diabetes, Belgrade, Serbia. ^[1] Primary Health Care Center, University of Montenegro, Faculty of Medicine, Podgorica, Montenegro. ^[2] VINČA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade - Department of Radiobiology and Molecular Genetics. ^[3] University of Belgrade Faculty of Medicine - Clinic of Endocrinology, Diabetes and Diseases of Metabolism. ^[4] Zemun Clinical Hospital, Faculty of Medicine, University of Belgrade - Department of Gastroenterology and Hepatology Belgrade, Serbia. ^[5]

关键词 FLI score Fib-4 NAFLD liver biopsy liver fibrosis t2DM

DOI 10.4183/aeb.2022.480

PMID 37152882

发布时间 2023-10-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Acta endocrinologica (Bucharest, Romania

480-487页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A non-invasive method for estimating the severity of liver steatosis and the risk of fibrosis in non-obese type 2 diabetes patients with NAFLD.

Acta endocrinologica (Bucharest, Romania

相似文献

Acta endocrinologica (Bucharest, Romania

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A non-invasive method for estimating the severity of liver steatosis and the risk of fibrosis in non-obese type 2 diabetes patients with NAFLD.

Acta endocrinologica (Bucharest, Romania

相似文献

Acta endocrinologica (Bucharest, Romania

相关期刊

检索历史清除